Indication: Transient Myeloproliferative Disorder (TMD)

Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)

Sub-indication: Transient Myeloproliferative Disorder (TMD)

Study Type: Specimen Study

Principal Investigator: Ashok Raj, M.D.
Norton Children's Cancer Institute, affiliated with the UofL School of Medicine

Sponsor: Sponsor: Children's Oncology Group (COG)

Learn more at ClinicalTrials.gov

Email for more information: NCRI-Cancer@NortonHealthcare.org

Search our entire site.